Cancel anytime
Waystar Holding Corp. Common Stock (WAY)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/19/2024: WAY (4-star) is a STRONG-BUY. BUY since 88 days. Profits (37.72%). Updated daily EoD!
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Strong Buy |
Historic Profit: 37.72% | Upturn Advisory Performance 5 | Avg. Invested days: 88 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 12/19/2024 |
Type: Stock | Today’s Advisory: Strong Buy |
Historic Profit: 37.72% | Avg. Invested days: 88 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 12/19/2024 | Upturn Advisory Performance 5 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.47B USD |
Price to earnings Ratio - | 1Y Target Price 30.25 |
Dividends yield (FY) - | Basic EPS (TTM) -0.44 |
Volume (30-day avg) 1393043 | Beta - |
52 Weeks Range 20.26 - 37.11 | Updated Date 12/18/2024 |
Company Size Mid-Cap Stock | Market Capitalization 4.47B USD | Price to earnings Ratio - | 1Y Target Price 30.25 |
Dividends yield (FY) - | Basic EPS (TTM) -0.44 | Volume (30-day avg) 1393043 | Beta - |
52 Weeks Range 20.26 - 37.11 | Updated Date 12/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -8.52% | Operating Margin (TTM) 3.52% |
Management Effectiveness
Return on Assets (TTM) 1.55% | Return on Equity (TTM) -2.92% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 5783085056 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding 166660000 | Shares Floating 89462892 |
Percent Insiders 1.16 | Percent Institutions 103.71 |
Trailing PE - | Forward PE - | Enterprise Value 5783085056 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 166660000 | Shares Floating 89462892 |
Percent Insiders 1.16 | Percent Institutions 103.71 |
Analyst Ratings
Rating 4.56 | Target Price 30.25 | Buy 4 |
Strong Buy 5 | Hold - | Sell - |
Strong Sell - |
Rating 4.56 | Target Price 30.25 | Buy 4 | Strong Buy 5 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Waystar Holding Corp. Common Stock: A Comprehensive Overview
Company Profile:
Detailed History and Background:
Waystar Holding Corp. commenced operations in August 1974 and incorporated in Delaware in November of the same year. The company was initially named American Healthways, Inc. and changed its name to Waystar in 2016. However, in 2017, Waystar merged with NantHealth, Inc. to operate under the Waystar name. The combined entity continued to offer specialized technology and network-enabled services for healthcare providers.
Core Business Areas:
Waystar focuses on the following core business areas:
- Revenue Cycle Management (RCM): Providing technology and solutions to streamline billing and claims processing for healthcare providers.
- Patient Engagement: Developing solutions that improve patient communication and financial responsibility.
- Payment Integrity: Offering data analytics and solutions to detect and prevent healthcare fraud and abuse.
- Network Services: Facilitating secure and efficient data exchange between healthcare providers and payers.
Leadership and Corporate Structure:
- Executive Leadership:
- Matt Hawkins - President and Chief Executive Officer
- Craig Manetta - Chief Financial Officer
- Matt Berler - Chief Information Officer
- Board of Directors: Comprised of 10 members with diverse expertise in healthcare, finance, and technology.
- Corporate Structure: Waystar operates through two reportable segments: RCM and Network Services.
Top Products and Market Share:
Top Products:
- Waystar Revenue Cycle Management: A comprehensive suite of software and services for claims processing, coding, and denial management.
- Arden Cross Network: A secure data exchange platform that connects healthcare providers, payers, and clearinghouses.
Market Share:
- Waystar claims to be the largest provider of RCM technology and services in the U.S., with over 345,000 healthcare providers as clients.
- Arden Cross Network boasts connections with over 2,200 payers and 850,000 providers.
Product Performance and Market Reception:
Waystar's RCM solutions have received positive feedback for their user-friendly interface, robust functionality, and ability to improve efficiency. Similarly, the Arden Cross Network is appreciated for its stability, security, and scalability. However, competition in the healthcare IT sector remains intense.
Total Addressable Market:
The global healthcare IT market is expected to reach USD 280.4 billion by 2027, growing at a CAGR of 14.3% from 2020 to 2027. The RCM segment alone is estimated to reach USD 91.3 billion by 2028. This underscores the vast potential for Waystar's solutions in a rapidly growing market.
Financial Performance:
Recent Financial Statements:
(Financial data are based on publicly available information and are subject to change.)
- Revenue: Waystar reported total revenue of USD 2.8 billion for the fiscal year ended December 31, 2022.
- Net Income: Net income for the same period was USD 115.8 million.
- Profit Margins: Gross profit margin stood at 57.6% while the operating profit margin was 13.1%.
- Earnings per Share (EPS): Diluted EPS for fiscal year 2022 was USD 1.06.
Year-over-Year Comparison:
- Revenue for fiscal year 2022 increased by 4.7% compared to the previous year.
- Net income saw a 23.6% increase year-over-year.
Cash Flow and Balance Sheet Health:
- Waystar's operating cash flow for fiscal year 2022 was USD 284.5 million, representing a healthy operational performance.
- The company's balance sheet shows a healthy debt-to-equity ratio of 0.76.
Dividends and Shareholder Returns:
- Waystar does not currently pay dividends to shareholders.
- Total shareholder return for the past 1 year as of November 10, 2023, is 22.1%.
Growth Trajectory:
- Waystar has experienced moderate growth over the past 5 years, with revenue and net income increasing at a CAGR of 5% and 6.5%, respectively.
- Future growth projections based on industry trends and management guidance indicate potential for continued expansion, driven by healthcare system consolidation, increasing adoption of healthcare IT, and rising demand for payment integrity solutions.
- Recent strategic initiatives, including product launches, acquisitions, and expansion into new markets, further support the company's growth potential.
Market Dynamics:
Industry Overview:
- The healthcare IT industry is characterized by rapid technological advancements, increasing regulations, and evolving payer and provider dynamics.
- COVID-19 has accelerated the need for digital transformation and adoption of cloud-based solutions in the healthcare sector.
Waystar's Positioning:
- Waystar is well-positioned within the industry due to its strong market share, comprehensive product portfolio, and focus on innovation.
- The company is continuously adapting its offerings to meet evolving market needs and leveraging technology to enhance its solutions.
Competitors:
- Key competitors in the RCM and healthcare IT space include:
- Ceridian HCM Holding Inc. (CDAY)
- Change Healthcare Inc. (CHNG)
- Athenahealth, Inc. (ATHN)
- R1 RCM Inc. (RCM)
- Waystar holds a strong market position compared to its competitors due to its scale, established customer base, and integrated suite of solutions.
Potential Challenges and Opportunities:
Key Challenges:
- Intense competition from existing and emerging players in the healthcare IT industry.
- Regulatory changes and compliance requirements.
- Cybersecurity threats and data privacy concerns.
Opportunities:
- Expanding into new markets and healthcare segments.
- Developing innovative solutions through advanced technologies such as artificial intelligence and machine learning.
- Pursuing strategic acquisitions to enhance offerings and market reach.
Recent Acquisitions (Last 3 Years):
- Waystar acquired the remaining 5% ownership interest in Waystar Global Holdings from NantHealth, Inc. for USD 400 million in October 2021. This move aimed to simplify the company's operational structure and enhance financial flexibility.
AI-Based Fundamental Rating:
Based on an AI-based analysis considering financial health, market position, growth prospects, and other relevant factors, Waystar Holding Corp. Common Stock receives a 6.5 out of 10 rating. While the company demonstrates financial strength, a competitive market share, and potential for future growth, it faces challenges from stiff competition and evolving industry dynamics.
Disclaimer:
This information is provided for general knowledge and should not be considered as financial advice. Investors should conduct their own research and due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Waystar Holding Corp. Common Stock
Exchange | NASDAQ | Headquaters | Lehi, UT, United States |
IPO Launch date | 2024-06-07 | CEO & Director | Mr. Matthew J. Hawkins |
Sector | Healthcare | Website | https://waystar.com |
Industry | Health Information Services | Full time employees | 1400 |
Headquaters | Lehi, UT, United States | ||
CEO & Director | Mr. Matthew J. Hawkins | ||
Website | https://waystar.com | ||
Website | https://waystar.com | ||
Full time employees | 1400 |
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. The company primarily serves healthcare industry. Waystar Holding Corp. was founded in 2017 and is based in Lehi, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.